Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SNAP29 ELISA Kit (AC3326)
Cat.#: ASET-1915
Specifications
Description Human SNAP29 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SNAP29 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.25 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2332 Human NT-4 ELISA Kit (AC3743) Quantitative inquiry ASET-2194 Guinea Pig Adiponectin ELISA Kit (AC3605) Quantitative inquiry ASET-1284 Human alpha B Crystallin ELISA Kit (AC2695) Quantitative inquiry ASET-1675 Mouse Reelin ELISA Kit (AC3086) Quantitative inquiry ASET-1565 Human BASP1 ELISA Kit (AC2976) Quantitative inquiry ASET-1207 Human ALDH1A1 ELISA Kit (AC2618) Quantitative inquiry ASET-2058 Mouse C Peptide ELISA Kit (AC3469) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-2003 Mouse EDG8 ELISA Kit (AC3414) Quantitative inquiry ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket